Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

Natural history of liver fibrosis progression in patients with chronic hepatitis C

1997 • 3,027 citations

Clinical Outcomes after Transfusion-Associated Hepatitis C

1995 • 1,228 citations

Epidemiology of hepatitis C

1997 • 1,112 citations

Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon

1986 • 980 citations

Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

1992 • 692 citations

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

1996 • 675 citations

Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy

1997 • 571 citations

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon

1996 • 498 citations

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

1998 • 474 citations

Side effects of ? interferon in chronic hepatitis C

1997 • 396 citations

Factors predictive of a beneficial response to therapy of hepatitis C

1997 • 339 citations

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1997 • 337 citations

Diagnostic tests for hepatitis C

1997 • 321 citations

Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C

1997 • 320 citations

Hepatitis C

1998 • 287 citations

Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

1997 • 259 citations

Therapy of hepatitis C: Overview

1997 • 221 citations

Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C

1995 • 188 citations

Therapy of hepatitis C: Patients with normal aminotransferase levels

1997 • 170 citations

Treatment of chronic hepatitis C with amantadine.

1997 • 145 citations

Extrahepatic manifestations of chronic viral hepatitis.

1997 • 137 citations

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

1996 • 123 citations

Hepatitis C after orthotopic liver transplantation

1997 • 107 citations

Therapy of hepatitis C: Alpha interferon and ribavirin

1997 • 105 citations

Therapy of hepatitis C: Re-treatment with alpha interferon

1997 • 103 citations

Therapy of hepatitis C: Consensus interferon trials

1997 • 97 citations

Management of hepatitis C

1998 • 95 citations

Long-term course of interferon-treated chronic hepatitis C

1998 • 83 citations

Therapy of hepatitis C: Other options

1997 • 76 citations

Therapy of hepatitis C: Patients with cirrhosis

1997 • 64 citations

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

1996 • 57 citations

Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.

1997 • 57 citations

Chronic Hepatitis with Combined Features of Autoimmune Chronic Hepatitis and Chronic Hepatitis C: Favorable Response to Prednisone and Azathioprine

1995 • 54 citations

Therapy of hepatitis C: Interferon alfa-2a trials

1997 • 48 citations

Therapy of hepatitis C: Interferon alfa-n1 trials

1997 • 47 citations

Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation

1995 • 27 citations

Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis

1995 • 26 citations

Autoimmune hepatitis and/or hepatitis C: How to decide

1996 • 15 citations

Hepatitis C virus infection in the immunocompromised patient.

1995 • 7 citations

Treatment of chronic hepatitis C in children

1999 • 7 citations

Lymphoblastoid interferon improves long-term response to a six month course of treatment when compared with recombinant interferon alpha 2b: Results of an international trial St. Louis U, U Sidney, Australia, Hospital Beaujon, Clichy, France, Virchow-Klinikum, Berlin, Hospital Ramon y Cajal, Madrid, Mt. Sinai Hospital, Toronto, Ospedale Molinette, Turin, Italy, UCSF, Burroughs Wellcome Co.

1995 • 4 citations